Autobio Diagnostics Co., Ltd.

SHSE:603658 Rapport sur les actions

Capitalisation boursière : CN¥23.3b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Autobio Diagnostics Croissance future

Future contrôle des critères 2/6

Autobio Diagnostics is forecast to grow earnings and revenue by 19.6% and 16.3% per annum respectively. EPS is expected to grow by 19.3% per annum. Return on equity is forecast to be 17.1% in 3 years.

Informations clés

19.6%

Taux de croissance des bénéfices

19.3%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices22.5%
Taux de croissance des recettes16.3%
Rendement futur des capitaux propres17.1%
Couverture par les analystes

Good

Dernière mise à jour20 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 09
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Jul 18
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

May 21
Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Feb 27
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Prévisions de croissance des bénéfices et des revenus

SHSE:603658 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20267,0292,238N/A2,3968
12/31/20256,0911,846N/A2,08011
12/31/20245,1311,518N/A1,63810
3/31/20244,4961,3006861,595N/A
12/31/20234,4441,2175691,470N/A
9/30/20234,4031,1696091,501N/A
6/30/20234,4791,1806561,525N/A
3/31/20234,4471,1696311,580N/A
12/31/20224,4421,1676201,558N/A
9/30/20224,3521,1565811,536N/A
6/30/20224,1591,0955081,508N/A
3/31/20223,9801,0423861,384N/A
12/31/20213,7669743951,461N/A
9/30/20213,6269504671,608N/A
6/30/20213,4508871251,339N/A
3/31/20213,245826-231,191N/A
12/31/20202,978748-121995N/A
9/30/20202,833751-361630N/A
6/30/20202,706728-202717N/A
3/31/20202,682746-35797N/A
12/31/20192,67977481843N/A
9/30/20192,46368944754N/A
6/30/20192,261636142685N/A
3/31/20192,062588216650N/A
12/31/20181,930563244654N/A
9/30/20181,777534215566N/A
6/30/20181,666502193537N/A
3/31/20181,574475167507N/A
12/31/20171,400447N/A482N/A
9/30/20171,271419N/A501N/A
6/30/20171,129393N/A461N/A
3/31/20171,030363N/A444N/A
12/31/2016980350N/A416N/A
9/30/2016898335N/A360N/A
6/30/2016837317N/A371N/A
3/31/2016752278N/A313N/A
12/31/2015716278N/A309N/A
12/31/2014563208N/A257N/A
12/31/2013409124N/A103N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 603658's forecast earnings growth (19.6% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 603658's earnings (19.6% per year) are forecast to grow slower than the CN market (21.9% per year).

Croissance élevée des bénéfices: 603658's earnings are forecast to grow, but not significantly.

Chiffre d'affaires vs marché: 603658's revenue (16.3% per year) is forecast to grow faster than the CN market (13.4% per year).

Croissance élevée des revenus: 603658's revenue (16.3% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 603658's Return on Equity is forecast to be low in 3 years time (17.1%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y